(-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption. (Q51351954)

4 April 2018

title

(-)-Epigallocathechin-3-gallate, an AMPK activator, decreases ovariectomy-induced bone loss by suppression of bone resorption. (English)

1 reference

4 April 2018

author

Hyung Jin Choi

3

1 reference

4 April 2018

author name string

Seung Hun Lee

1

1 reference

4 April 2018

Beom-Jun Kim

2

1 reference

4 April 2018

Sun Wook Cho

4

1 reference

4 April 2018

Chan Soo Shin

5

1 reference

4 April 2018

Sook-Young Park

6

1 reference

4 April 2018

Young-Sun Lee

7

1 reference

4 April 2018

Sun-Young Lee

8

1 reference

4 April 2018

Hong-Hee Kim

9

1 reference

4 April 2018

Ghi Su Kim

10

1 reference

4 April 2018

Jung-Min Koh

11

1 reference

4 April 2018

language of work or name

English

0 references

publication date

21 March 2012

1 reference

4 April 2018

Calcified Tissue International

published in

1 reference

4 April 2018

volume

90

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

404-410

1 reference

4 April 2018

Skeletal remodeling in health and disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Mechanisms of anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

AMPK activators--potential therapeutics for metabolic and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

AMP-activated protein kinase is involved in COX-2 expression in response to ultrasound in cultured osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Osteoblast differentiation is functionally associated with decreased AMP kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Efficacy of berberine in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Measuring and improving adherence to osteoporosis pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Molecular mechanisms in coupling of bone formation to resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Osteoclast-osteoblast communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Anti-obesity effects of green tea: from bedside to bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Leptin and the sympathetic connection of fat to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

The emergence of the metabolic syndrome with menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Can EGCG reduce abdominal fat in obese subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-012-9584-7

10.1007/S00223-012-9584-7

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018